Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Journal of the American College of Cardiology|July 28, 2018
A Clinician's Guide for Trending Cardiovascular Nutrition Controversies: Part IIAndrew M Freeman, Pamela B Morris, Karen Aspry, et al.
The Analyst|July 9, 2020
Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndromeAndrew M Shaw, Christopher Hyde, Blair Merrick, et al.
Journal of Diabetes Science and Technology|April 4, 2017
Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial SubstudyKatharine D Barnard, Timothy Wysocki, Vanessa Ully, et al.
The American Journal of Medicine|September 12, 2021
Trending Nutrition Controversies #3: Top Controversies in 2021Monica Aggarwal, Andrew M Freeman, Emilio Ros, et al.
JAMA Cardiology|July 21, 2016
Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical TrialH Kirk Hammond, William F Penny, Jay H Traverse, et al.
The American Journal of Medicine|February 8, 2022
Controversial Dietary Patterns: A High Yield Primer for CliniciansMonica Aggarwal, Emilio Ros, Kathleen Allen, et al.
The New England Journal of Medicine|September 18, 2015
Home Use of an Artificial Beta Cell in Type 1 DiabetesH Thabit, M Tauschmann, J M Allen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2012
SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago)R Ubillas, S D Jolad, R C Bruening, et al.
Lancet (London, England)|April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyF van Leth, P Phanuphak, K Ruxrungtham, et al.
Blood Advances|April 25, 2018
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohortMaximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
Pageof 32